A Multicenter Randomized Controlled Trial to Preliminarily Evaluate the Efficacy of Online Peer Support for Patients with Breast Cancer.

A Multicenter Randomized Controlled Trial to Preliminarily Evaluate the Efficacy of Online Peer Support for Patients with Breast Cancer. - HOPE-BC: Helping each Other by Peer Empowerment for Breast Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000056741

Enrollment

Registered

2025-01-17

Start date

2025-02-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage breast cancer

Interventions

Peer support Group Waiting Group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Patients aged 18 and over at the time of informed consent 2) Femele 3) Early -stage breast cancer patients 4) Patients within three years after early -stage breast cancer treatment /If only surgery is planned, patients can be enrolled after surgery. /If postoperative adjuvant therapy is planned, patients can be enrolled after completion or discontinuation of the planned adjuvant therapy. However, patients can be enrolled before completion or discontinuation of administering hormone therapy as a monotherapy. 5) Patients who are able to use the Decentralized Clinical Trial (DCT) system E.g., patients who use email and the Internet on a daily basis. 6) Patients who can provide consent via eConsent.

Exclusion criteria

Exclusion criteria: 1)Patients with active concurrent cancer. * Lesions equivalent to carcinoma in situ or mucosal carcinoma that can be cured with local therapy are not considered active concurrent cancers. 2) Patients deemed ineligible by the investigator or others, regardless of the reason.

Design outcomes

Primary

Measure	Time frame
UCLA Loneliness Scale after 1 week of peer support	—

Secondary

Measure	Time frame
1) Satisfaction with peer support (as rated by Numerical Rating Scale [NRS]) 2) Usefulness and evaluation of peer support 3) Generalized Anxiety Disorder -7 (GAD -7) Japanese version 4) Patient Health Questionnaire -9 (PHQ -9) Japanese version 5) Concerns about Recurrence scale Japanese version: CARS -J (CARS -J) 6) Short -form Supportive Care Needs Survey (SCNS -SF34) Japanese version (SCNS -SF34 -J) 7) Modified Depression and Anxiety Mood Scale (mDAMS) Japanese version 8) European Organization for Research and Treatment of Cancer (EORTC) QLQ -C30 Japanese version	—

Measure

Time frame

1) Satisfaction with peer support (as rated by Numerical Rating Scale [NRS]) 2) Usefulness and evaluation of peer support 3) Generalized Anxiety Disorder -7 (GAD -7) Japanese version 4) Patient Health Questionnaire -9 (PHQ -9) Japanese version 5) Concerns about Recurrence scale Japanese version: CARS -J (CARS -J) 6) Short -form Supportive Care Needs Survey (SCNS -SF34) Japanese version (SCNS -SF34 -J) 7) Modified Depression and Anxiety Mood Scale (mDAMS) Japanese version 8) European Organization for Research and Treatment of Cancer (EORTC) QLQ -C30 Japanese version

—

Countries

Japan

Contacts

Public ContactShin Nakajima

Daiichi Sankyo Co., Ltd Global DX HaaS Planning Department

Izutani.tadahiro.sa@daiichisankyo.co.jp03-6225-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026